Agenus在季度损失较少的情况下击败了分析师的预期,但其库存以2.15美元开放。 Agenus beat analyst expectations with a smaller quarterly loss, but its stock opened at $2.15.

生物技术公司Agenus报告每季度每股损失2.04美元,比分析师预期损失2.36美元。 Biotech firm Agenus reported a quarterly loss of $2.04 per share, beating analysts' expectations of a $2.36 loss. 尽管收入令人意外,但Agenus股票以2.15美元开放。 Despite the positive earnings surprise, Agenus stock opened at $2.15. 该公司专门从事免疫肿瘤产品,市场上限为5 044万美元,价格与收入的比率为-0.19。 The company, which specializes in immuno-oncology products, has a market cap of $50.44 million and a price-to-earnings ratio of -0.19. 在过去一年中,Agenus股票的交易额在2.13美元至19.69美元之间。 Agenus stock has traded between $2.13 and $19.69 over the past year.